This Morning's Technical Outlook on Services Stocks -- GNC Holdings, McKesson, AmerisourceBergen, and Cardinal Health

Wednesday, December 20, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Dec. 20, 2017 /PRNewswire/ -- In keeping with the commitment to dynamically provide members with timely information, has issued free tailored Stock Review on GNC, MCK, ABC, and CAH which is a click away at On Tuesday, benchmark US indices were in bearish colors as the NASDAQ Composite closed the trading session
down 0.44%; the Dow Jones Industrial Average edged 0.15% lower; and the S&P 500 was down 0.32%. US markets made broad based losses with all sectors finishing the day in red. Pre-market today, reviews these four Services stocks: GNC Holdings Inc. (NYSE: GNC), McKesson Corp. (NYSE: MCK), AmerisourceBergen Corp. (NYSE: ABC), and Cardinal Health Inc. (NYSE: CAH). With Wall St. Equities' free research reports get an edge over stock markets, sign up now at:

GNC Holdings

Pittsburgh, Pennsylvania headquartered GNC Holdings Inc.'s stock finished Tuesday's session 3.48% lower at $4.71. A total volume of 2.10 million shares was traded. The stock is trading below its 50-day moving average by 26.60%. Furthermore, shares of GNC Holdings, which together with its subsidiaries, operates as a specialty retailer of health, wellness, and performance products, have a Relative Strength Index (RSI) of 33.20. Our free and thorough report on GNC awaits you at:


Shares in San Francisco, California headquartered McKesson Corp. ended at $159.97, down 0.18% from the last trading session. The stock recorded a trading volume of 2.04 million shares. The Company's shares have gained 12.55% in the last one month, 13.01% in the last twelve months, and 13.90% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 9.63% and 5.73%, respectively. Moreover, shares of McKesson, which provides pharmaceuticals and medical supplies in the US and internationally, have an RSI of 65.30.

On December 04th, 2017, research firm Deutsche Bank initiated a 'Buy' rating on the Company's stock, with a target price of $175 per share. MCK's complimentary research coverage is a few simple steps away at:


Chesterbrook, Pennsylvania headquartered AmerisourceBergen Corp.'s stock ended yesterday's session 1.50% higher at $93.79 with a total trading volume of 2.01 million shares. The Company's shares have advanced 18.96% in the past month, 17.97% over the previous three months, 19.60% in the last twelve months, and 19.95% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 15.67% and 9.74%, respectively. Additionally, shares of AmerisourceBergen, which sources and distributes pharmaceutical products in the US and internationally, have an RSI of 76.38.

On December 15th, 2017, research firm Goldman upgraded the Company's stock rating from 'Neutral' to 'Buy'. Are you already registered with Wall St. Equities? Do so now for free, and get the report on ABC at:

Cardinal Health

On Tuesday, shares in Dublin, Ohio headquartered Cardinal Health Inc. recorded a trading volume of 3.96 million shares, which was above their three months average volume of 3.40 million shares. The stock finished the day 0.99% higher at $63.01. The Company's shares have advanced 9.56% in the last one month. The stock is trading above its 50-day moving average by 3.02%. Furthermore, shares of Cardinal Health, which operates as an integrated healthcare services and products company worldwide, have an RSI of 59.96.

On December 04th, 2017, research firm Deutsche Bank initiated a 'Hold' rating on the Company's stock, with a target price of $64 per share. Aspiring Member, please take a moment to register below for your free research report on CAH at:


Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

WSE has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit


For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:Email: Phone number: +21-32-044-483Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

Cision View original content:

SOURCE Wall St. Equities


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store